scholarly article | Q13442814 |
P50 | author | Joseph Vita | Q42637117 |
Orian S Shirihai | Q37837313 | ||
Naomi Hamburg | Q42631325 | ||
P2093 | author name string | Kai Chen | |
Lija Joseph | |||
Mai-Ann Duess | |||
Matthew A Kluge | |||
Alissa A Frame | |||
Michael E Widlansky | |||
Mor-Li Hartman | |||
Brian Kim | |||
Corey E Tabit | |||
Sherene M Shenouda | |||
Monika Holbrook | |||
Guoquan Xu | |||
Aaron Levit | |||
Tara L Caiano | |||
P2860 | cites work | Biopsy coupled to quantitative immunofluorescence: a new method to study the human vascular endothelium | Q43884350 |
Free radicals mediate endothelial cell dysfunction caused by elevated glucose | Q45352637 | ||
Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6. | Q47370842 | ||
High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells | Q73190327 | ||
Nitric oxide-dependent vasodilation in human subjects | Q78659297 | ||
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy | Q24652230 | ||
Biochemistry and molecular cell biology of diabetic complications | Q28131781 | ||
Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site | Q28363492 | ||
Subcellular localization of Nox4 and regulation in diabetes | Q28566200 | ||
Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity | Q28572807 | ||
Mitochondrial dysfunction and type 2 diabetes | Q29617913 | ||
Update on nitric oxide-dependent vasodilation in human subjects | Q30486656 | ||
Mechanisms underlying endothelial dysfunction in diabetes mellitus | Q31829307 | ||
Small molecule inhibitors of mitochondrial division: tools that translate basic biological research into medicine | Q33627091 | ||
Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications | Q33901576 | ||
Mitochondrial fragmentation and superoxide anion production in coronary endothelial cells from a mouse model of type 1 diabetes | Q33940901 | ||
High glucose disrupts mitochondrial morphology in retinal endothelial cells: implications for diabetic retinopathy | Q33947328 | ||
Altered mitochondrial membrane potential, mass, and morphology in the mononuclear cells of humans with type 2 diabetes | Q33996111 | ||
Vascular oxidative stress: the common link in hypertensive and diabetic vascular disease | Q34479731 | ||
Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology | Q34479807 | ||
Selective fluorescent imaging of superoxide in vivo using ethidium-based probes | Q35062293 | ||
Mitochondrial fusion, fission and autophagy as a quality control axis: the bioenergetic view | Q37179623 | ||
Assessment of endothelial function using digital pulse amplitude tonometry | Q37184081 | ||
Mitochondrial networking protects beta-cells from nutrient-induced apoptosis. | Q37360471 | ||
Mitochondrial dynamics in mammalian health and disease | Q37543838 | ||
Role of mitochondrial dynamics proteins in the pathophysiology of obesity and type 2 diabetes | Q37585742 | ||
Hyperglycemic conditions affect shape and Ca2+ homeostasis of mitochondria in endothelial cells | Q40509731 | ||
Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. | Q40888989 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | endothelium | Q111140 |
P304 | page(s) | 444-453 | |
P577 | publication date | 2011-07-11 | |
P1433 | published in | Circulation | Q578091 |
P1476 | title | Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus | |
P478 | volume | 124 |
Q35894953 | A Systematic Review of the Efficacy of Bioactive Compounds in Cardiovascular Disease: Phenolic Compounds |
Q41161606 | A Targeted Mutation Identified through pKa Measurements Indicates a Postrecruitment Role for Fis1 in Yeast Mitochondrial Fission. |
Q26850196 | A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation |
Q90288299 | Accelerated cerebral vascular injury in diabetes is associated with vascular smooth muscle cell dysfunction |
Q36463640 | Acute effect of mineralocorticoid receptor antagonism on vascular function in healthy older adults |
Q92839693 | Advanced glycation end products influence mitochondrial fusion-fission dynamics through RAGE in human aortic endothelial cells |
Q36603344 | Adverse alterations in mitochondrial function contribute to type 2 diabetes mellitus-related endothelial dysfunction in humans |
Q33580367 | Aerobic interval training attenuates mitochondrial dysfunction in rats post-myocardial infarction: roles of mitochondrial network dynamics |
Q47558706 | An Energetic View of Stress: Focus on Mitochondria |
Q42135566 | Autophagy Is Impaired in Neutrophils from Streptozotocin-Induced Diabetic Rats |
Q38845649 | Autophagy protects human brain microvascular endothelial cells against methylglyoxal-induced injuries, reproducible in a cerebral ischemic model in diabetic rats. |
Q37251110 | C-peptide activates AMPKα and prevents ROS-mediated mitochondrial fission and endothelial apoptosis in diabetes |
Q92715493 | CTRP3 Protects against High Glucose-Induced Cell Injury in Human Umbilical Vein Endothelial Cells |
Q36738111 | Cadmium induced Drp1-dependent mitochondrial fragmentation by disturbing calcium homeostasis in its hepatotoxicity |
Q38876792 | Celastrol Protects against Antimycin A-Induced Insulin Resistance in Human Skeletal Muscle Cells. |
Q38134022 | Cellular and molecular mechanisms of endothelial dysfunction in diabetes |
Q36252915 | Changes in microvascular reactivity after cardiopulmonary bypass in patients with poorly controlled versus controlled diabetes |
Q36102609 | Changes, and the Relevance Thereof, in Mitochondrial Morphology during Differentiation into Endothelial Cells. |
Q38427211 | Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes |
Q48188587 | Clinical impact of oral antidiabetic medications in heart failure patients. |
Q91712161 | Contribution of Mitochondrial DNA Variation to Chronic Disease in East Asian Populations |
Q41377093 | Crosstalk between Mitochondrial Fission and Oxidative Stress in Paraquat-Induced Apoptosis in Mouse Alveolar Type II Cells |
Q47203299 | Decreased coronary arteriolar response to KCa channel opener after cardioplegic arrest in diabetic patients. |
Q36126327 | Decreased coronary microvascular reactivity after cardioplegic arrest in patients with uncontrolled diabetes mellitus. |
Q41913584 | Deletion of PRKAA triggers mitochondrial fission by inhibiting the autophagy-dependent degradation of DNM1L. |
Q47295169 | Development and Validation of 2D Difference Intensity Analysis for Chemical Library Screening by Protein-Detected NMR. |
Q87771640 | Dietary supplementation with fish oil alters the expression levels of proteins governing mitochondrial dynamics and prevents high-fat diet-induced endothelial dysfunction |
Q36532336 | Differential Mitochondrial Adaptation in Primary Vascular Smooth Muscle Cells from a Diabetic Rat Model. |
Q36553399 | Differential impairment of adherens-junction expression/phosphorylation after cardioplegia in diabetic versus non-diabetic patients. |
Q36292177 | Downregulation of mitochondrial connexin 43 by high glucose triggers mitochondrial shape change and cytochrome C release in retinal endothelial cells |
Q37631600 | Drp1-Dependent Mitochondrial Fission Plays Critical Roles in Physiological and Pathological Progresses in Mammals |
Q99350201 | Drp1-dependent mitochondrial fission in cardiovascular disease |
Q35532253 | Drp1-mediated mitochondrial abnormalities link to synaptic injury in diabetes model |
Q49487791 | Dynamic Changes of Mitochondrial Fusion and Fission in Brain Injury after Cardiac Arrest in Rats. |
Q39125994 | Dynamin-related protein 1 mediates low glucose-induced endothelial dysfunction in human arterioles |
Q42551085 | Effects of (-)-epicatechin and derivatives on nitric oxide mediated induction of mitochondrial proteins. |
Q37088633 | Elevated Angiopoietin-2 Level in Patients With Continuous-Flow Left Ventricular Assist Devices Leads to Altered Angiogenesis and Is Associated With Higher Nonsurgical Bleeding. |
Q34239967 | Emerging roles of mitochondria ROS in atherosclerotic lesions: causation or association? |
Q55384960 | Empagliflozin normalizes the size and number of mitochondria and prevents reduction in mitochondrial size after myocardial infarction in diabetic hearts. |
Q34518725 | Endothelial AMPK activation induces mitochondrial biogenesis and stress adaptation via eNOS-dependent mTORC1 signaling. |
Q49787990 | Endothelial Cell Metabolism. |
Q30519471 | Endothelial mitochondria--less respiration, more integration |
Q37639902 | Endothelium and its alterations in cardiovascular diseases: life style intervention |
Q90484556 | Epigenetic Control of Mitochondrial Function in the Vasculature |
Q38073159 | Epigenetics of insulin resistance: an emerging field in translational medicine |
Q41880836 | Ex vivo imaging of excised tissue using vital dyes and confocal microscopy |
Q35843607 | Explaining the increased mortality in type 1 diabetes |
Q95643662 | FGF21 mitigates atherosclerosis via inhibition of NLRP3 inflammasome-mediated vascular endothelial cells pyroptosis |
Q89107282 | Flavorings in Tobacco Products Induce Endothelial Cell Dysfunction |
Q38296599 | Fluid Mechanical Forces and Endothelial Mitochondria: A Bioengineering Perspective |
Q37446931 | From structure to function: mitochondrial morphology, motion and shaping in vascular smooth muscle |
Q47571604 | Gender and cardiovascular disease: are sex-biased microRNA networks a driving force behind heart failure with preserved ejection fraction in women? |
Q94464138 | Gerontoxanthone I and Macluraxanthone Induce Mitophagy and Attenuate Ischemia/Reperfusion Injury |
Q36003163 | Glucocorticoids Suppress Mitochondrial Oxidant Production via Upregulation of Uncoupling Protein 2 in Hyperglycemic Endothelial Cells |
Q60922054 | HSP22 suppresses diabetes-induced endothelial injury by inhibiting mitochondrial reactive oxygen species formation |
Q38482322 | Heart failure with preserved ejection fraction: Defining the function of ROS and NO. |
Q83361590 | Hexosamine pathway activation and O-linked-N-acetylglucosamine: novel mediators of endothelial dysfunction in hyperglycemia and diabetes |
Q37536275 | High Glucose Attenuates Anesthetic Cardioprotection in Stem-Cell-Derived Cardiomyocytes: The Role of Reactive Oxygen Species and Mitochondrial Fission |
Q33769436 | High Glucose Induces Mitochondrial Dysfunction in Retinal Müller Cells: Implications for Diabetic Retinopathy |
Q35591494 | High glucose induces mitochondrial morphology and metabolic changes in retinal pericytes |
Q35137676 | Higher levels of adiponectin in vascular endothelial cells are associated with greater brachial artery flow-mediated dilation in older adults |
Q48247164 | Human heart failure with preserved ejection versus feline cardiomyopathy: what can we learn from both veterinary and human medicine? |
Q33738536 | Hypoxia-induced pulmonary hypertension in type 2 diabetic mice |
Q64916442 | Impaired Mitochondrial Fusion and Oxidative Phosphorylation Triggered by High Glucose Is Mediated by Tom22 in Endothelial Cells. |
Q93082044 | Inflammatory cytokines associated with cancer growth induce mitochondria and cytoskeleton alterations in cardiomyocytes |
Q27021840 | Inorganic nitrite supplementation for healthy arterial aging |
Q36877661 | Intravenous Lipid Infusion Induces Endoplasmic Reticulum Stress in Endothelial Cells and Blood Mononuclear Cells of Healthy Adults |
Q46247181 | Ionic signalling and mitochondrial dynamics |
Q47316049 | Laminar Shear Stress Promotes Mitochondrial Homeostasis in Endothelial Cells. |
Q36635352 | Linking the metabolic state and mitochondrial DNA in chronic disease, health, and aging |
Q34269858 | Lipotoxicity contributes to endothelial dysfunction: a focus on the contribution from ceramide. |
Q58127020 | Liraglutide Treatment Reduces Endothelial Endoplasmic Reticulum Stress and Insulin Resistance in Patients With Diabetes Mellitus |
Q35935796 | Lysocardiolipin acyltransferase 1 (ALCAT1) controls mitochondrial DNA fidelity and biogenesis through modulation of MFN2 expression |
Q38882106 | Manipulating Angiogenesis by Targeting Endothelial Metabolism: Hitting the Engine Rather than the Drivers-A New Perspective? |
Q45792955 | Mechanisms of Osteoarthritic Pain. Studies in Humans and Experimental Models |
Q36377252 | Mechanisms of lipotoxicity in the cardiovascular system |
Q64055591 | Melatonin Affects Mitochondrial Fission/Fusion Dynamics in the Diabetic Retina |
Q58799669 | Mesenchymal stem cells ameliorate hyperglycemia-induced endothelial injury through modulation of mitophagy |
Q46478331 | Metformin Suppresses Diabetes-Accelerated Atherosclerosis via the Inhibition of Drp1-Mediated Mitochondrial Fission |
Q50420830 | Methods for imaging mammalian mitochondrial morphology: A prospective on MitoGraph. |
Q35031976 | Mineralocorticoid receptors modulate vascular endothelial function in human obesity |
Q35368510 | MitProNet: A knowledgebase and analysis platform of proteome, interactome and diseases for mammalian mitochondria |
Q36979168 | Mitochondria and endothelial function |
Q39266998 | Mitochondria in endothelial cells: Sensors and integrators of environmental cues. |
Q38019459 | Mitochondria in heart failure: the emerging role of mitochondrial dynamics |
Q33600464 | Mitochondria, endothelial cell function, and vascular diseases |
Q51746246 | Mitochondria-targeted antioxidant (MitoQ) ameliorates age-related arterial endothelial dysfunction in mice. |
Q89786540 | Mitochondrial 8-hydroxy-2'-deoxyguanosine and coronary artery disease in patients with type 2 diabetes mellitus |
Q93376504 | Mitochondrial ATP production provides long-range control of endothelial inositol trisphosphate-evoked calcium signaling |
Q36758612 | Mitochondrial DNA damage and vascular function in patients with diabetes mellitus and atherosclerotic cardiovascular disease |
Q39008813 | Mitochondrial Dynamics as a Therapeutic Target for Treating Cardiac Diseases |
Q55007433 | Mitochondrial Dynamics in Type 2 Diabetes and Cancer. |
Q39262741 | Mitochondrial Reactive Oxygen Species and Kidney Hypoxia in the Development of Diabetic Nephropathy |
Q26774784 | Mitochondrial Regulation of the Muscle Microenvironment in Critical Limb Ischemia |
Q93080735 | Mitochondrial Structural Changes in the Pathogenesis of Diabetic Retinopathy |
Q28390964 | Mitochondrial division and fusion in metabolism |
Q38625440 | Mitochondrial dynamics, mitophagy and cardiovascular disease. |
Q36728778 | Mitochondrial dynamics: regulatory mechanisms and emerging role in renal pathophysiology |
Q39005762 | Mitochondrial dysfunction and oxidative stress in metabolic disorders - A step towards mitochondria based therapeutic strategies |
Q38241510 | Mitochondrial dysfunction as a central event for mechanisms underlying insulin resistance: the roles of long chain fatty acids |
Q38128781 | Mitochondrial fission-fusion as an emerging key regulator of cell proliferation and differentiation |
Q28383025 | Mitochondrial function in vascular endothelial cell in diabetes |
Q37727246 | Mitochondrial mitophagy in mesenteric artery remodeling in hyperhomocysteinemia |
Q36700290 | Mitochondrial morphology transitions and functions: implications for retrograde signaling? |
Q26852770 | Mitochondrial morphology-emerging role in bioenergetics |
Q30573140 | Mitochondrial motility and vascular smooth muscle proliferation |
Q46432453 | Mitochondrial redox plays a critical role in the paradoxical effects of NAPDH oxidase-derived ROS on coronary endothelium. |
Q91137781 | Mitochondrial regulation of diabetic vascular disease: an emerging opportunity |
Q39270199 | Mitochondrial-targeted nitroxides disrupt mitochondrial architecture and inhibit expression of peroxiredoxin 3 and FOXM1 in malignant mesothelioma cells |
Q42083837 | Modulating mitochondrial fission to lower diabetic oxidative stress |
Q91588804 | Molecular Dysfunction and Phenotypic Derangement in Diabetic Cardiomyopathy |
Q38125279 | Molecular biology of atherosclerosis |
Q38572485 | Molecular insight and pharmacological approaches targeting mitochondrial dynamics in skeletal muscle during obesity |
Q28384316 | Molecular mechanisms mediating mitochondrial dynamics and mitophagy and their functional roles in the cardiovascular system |
Q34099937 | Molecular mechanisms of vascular dysfunction and cardiovascular biomarkers in type 2 diabetes. |
Q38252544 | Molecular pathways of arterial aging |
Q35148462 | Molecular strategies for targeting antioxidants to mitochondria: therapeutic implications. |
Q27006036 | Morphological control of mitochondrial bioenergetics |
Q60960382 | Neuropilin-1 Controls Endothelial Homeostasis by Regulating Mitochondrial Function and Iron-Dependent Oxidative Stress |
Q64118155 | New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease |
Q37959805 | New roles for mitochondria in cell death in the reperfused myocardium |
Q35089868 | Nitric oxide and mitochondria in metabolic syndrome. |
Q36923959 | Nitric oxide regulates vascular adaptive mitochondrial dynamics |
Q37525237 | Nitrosonifedipine ameliorates the progression of type 2 diabetic nephropathy by exerting antioxidative effects |
Q27320797 | Novel super-resolution capable mitochondrial probe, MitoRed AIE, enables assessment of real-time molecular mitochondrial dynamics |
Q92890466 | Ovarian mitochondrial dynamics and cell fate regulation in an androgen-induced rat model of polycystic ovarian syndrome |
Q64997351 | Overexpression of hexokinase 2 reduces mitochondrial calcium overload in coronary endothelial cells of type 2 diabetic mice. |
Q92290748 | Oxidative Stress in the Pathogenesis and Evolution of Chronic Kidney Disease: Untangling Ariadne's Thread |
Q54977897 | Oxidative Stress, Apoptosis, and Mitochondrial Function in Diabetic Nephropathy. |
Q35995740 | Perspectives on: SGP symposium on mitochondrial physiology and medicine: what comes first, misshape or dysfunction? The view from metabolic excess |
Q51366038 | Phyllanthus urinaria's Inhibition of Human Osteosarcoma Xenografts Growth in Mice is Associated with Modulation of Mitochondrial Fission/Fusion Machinery. |
Q35324715 | Protective role of PGC-1α in diabetic nephropathy is associated with the inhibition of ROS through mitochondrial dynamic remodeling |
Q36610687 | Protein kinase C-β contributes to impaired endothelial insulin signaling in humans with diabetes mellitus |
Q64247403 | Quantitative 3D Mapping of the Human Skeletal Muscle Mitochondrial Network |
Q88487528 | Reactive Oxygen Species in Metabolic and Inflammatory Signaling |
Q27021131 | Recent advances in mitochondrial research |
Q54956778 | Recent novel approaches to limit oxidative stress and inflammation in diabetic complications. |
Q89167879 | Redox Regulation of Mitochondrial Fission Protein Drp1 by Protein Disulfide Isomerase Limits Endothelial Senescence |
Q28383361 | Redox regulation of mitochondrial function |
Q51245044 | Reduced mitochondrial DNA content in lymphocytes is associated with insulin resistance and inflammation in patients with impaired fasting glucose. |
Q37599302 | Relation of mitochondrial oxygen consumption in peripheral blood mononuclear cells to vascular function in type 2 diabetes mellitus |
Q37021145 | Restoration of autophagy in endothelial cells from patients with diabetes mellitus improves nitric oxide signaling |
Q37251144 | Rhein protects pancreatic β-cells from dynamin-related protein-1-mediated mitochondrial fission and cell apoptosis under hyperglycemia |
Q39035700 | Role of endoplasmic reticulum stress signalling in diabetic endothelial dysfunction and atherosclerosis |
Q53580562 | Role of mitochondrial dysfunction in hyperglycaemia-induced coronary microvascular dysfunction: Protective role of resveratrol. |
Q36713609 | SIRT3 Deficiency Induces Endothelial Insulin Resistance and Blunts Endothelial-Dependent Vasorelaxation in Mice and Human with Obesity |
Q35060739 | Saxagliptin restores vascular mitochondrial exercise response in the Goto-Kakizaki rat |
Q57825924 | Sex differences of oxidative stress markers in young healthy subjects are marker-specific in plasma but not in saliva |
Q47107210 | Significant Association Between Low Mitochondrial DNA Content in Peripheral Blood Leukocytes and Ischemic Stroke |
Q37595420 | Tanshinone IIA induces intrinsic apoptosis in osteosarcoma cells both in vivo and in vitro associated with mitochondrial dysfunction |
Q39155198 | Target acquired: Selective autophagy in cardiometabolic disease |
Q46897510 | Targeting prolyl-isomerase Pin1 prevents mitochondrial oxidative stress and vascular dysfunction: insights in patients with diabetes |
Q46317449 | Tetrahydrocurcumin ameliorates homocysteine-mediated mitochondrial remodeling in brain endothelial cells. |
Q47156296 | The Cladophora glomerata Enriched by Biosorption Process in Cr(III) Improves Viability, and Reduces Oxidative Stress and Apoptosis in Equine Metabolic Syndrome Derived Adipose Mesenchymal Stromal Stem Cells (ASCs) and Their Extracellular Vesicles (M |
Q26747310 | The Role of Mitochondrial Reactive Oxygen Species in Cardiovascular Injury and Protective Strategies |
Q98289614 | The Role of Oxidative Stress in Physiopathology and Pharmacological Treatment with Pro- and Antioxidant Properties in Chronic Diseases |
Q90478656 | The Vascular Consequences of Metabolic Syndrome: Rodent Models, Endothelial Dysfunction, and Current Therapies |
Q36672866 | The endothelium in diabetes: its role in insulin access and diabetic complications |
Q55414253 | The uremic toxin hippurate promotes endothelial dysfunction via the activation of Drp1-mediated mitochondrial fission. |
Q61814333 | Therapeutic Options Targeting Oxidative Stress, Mitochondrial Dysfunction and Inflammation to Hinder the Progression of Vascular Complications of Diabetes |
Q50298511 | Therapeutic Potential of Modulating MicroRNA in Peripheral Artery Disease |
Q39225879 | Toll-like receptor 4 mediates vascular remodeling in hyperhomocysteinemia. |
Q37729941 | Traditional Chinese medicine formula Qing Huo Yi Hao as superoxide anion scavenger in high glucose-treated endothelial cells. |
Q28395286 | Translating the basic knowledge of mitochondrial functions to metabolic therapy: role of L-carnitine |
Q38111635 | Translational physiology: from molecules to public health |
Q37724172 | Treating Diabetes with Exercise - Focus on the Microvasculature |
Q47124541 | Tumor necrosis factor-α levels and non-surgical bleeding in continuous-flow left ventricular assist devices |
Q88985401 | Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy |
Q95660466 | Vesicular transport mediates the uptake of cytoplasmic proteins into mitochondria in Drosophila melanogaster |
Q93168764 | Vildagliptin improves high glucose-induced endothelial mitochondrial dysfunction via inhibiting mitochondrial fission |
Q37538226 | Voluntary aerobic exercise increases arterial resilience and mitochondrial health with aging in mice |
Q35862481 | bFGF-Regulating MAPKs Are Involved in High Glucose-Mediated ROS Production and Delay of Vascular Endothelial Cell Migration |
Q37412089 | l-Citrulline Protects from Kidney Damage in Type 1 Diabetic Mice |
Search more.